Attention Members: Manufacturer recall of Lamotrigine 100 mg tablets

Taro Pharmaceuticals is voluntarily recalling one lot of Lamotrigine tablets. The Food and Drug Administration (FDA) classified this as a Class I Recall on February 19, 2020.

A single lot of Lamotrigine 100 mg tablets was found to have been cross-contaminated with a small amount of another drug substance (Enalapril Maleate).

Your health and safety are important. Please talk to your doctor about this recall at your next visit.

Please visit taro.com or https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/taro-pharmaceuticals-usa-inc-issues-voluntary-nationwide-recall-lamotrigine-tablets-usp-100-mg-100 for more information about this recall. You can also call the Horizon NJ Health Pharmacy Help Desk at 1-800-682-9094 x81016 (TTY 711), Monday through Friday, 8 a.m. to 6:30 p.m., and Saturday 8 a.m. to 4:30 p.m., Eastern Time.

Published on: March 3, 2020, 04:21 AM ET
Last updated on: March 4, 2020, 08:10 AM ET